[
  {
    "CASNum": "80288-49-9",
    "CSN_Catalog_Num": "CSN22095",
    "Product_Name": "Furafylline",
    "Synonyms": "/",
    "Target": "P450",
    "Pathway": "Metabolic Enzyme",
    "Brief": "Furafylline is a potent and selective inhibitor of human cytochrome P450IA2 with IC50 of 0.07 μM.",
    "Solubility": "DMSO: 12.5 mg/mL ",
    "MolFormula": "C12H12N4O3",
    "MolWeight": "260.2500",
    "SMILES": "O=C(N1C)N(CC2=CC=CO2)C3=C(NC(C)=N3)C1=O",
    "Plate layout": "CSN-L1012-1-A1"
  },
  {
    "CASNum": "1394820-69-9",
    "CSN_Catalog_Num": "CSN24062",
    "Product_Name": "NIngetinib",
    "Synonyms": "/",
    "Target": "c-Met/HGFR",
    "Pathway": "Protein Tyrosine Kinase/RTK",
    "Brief": "Ningetinib is an inhibitor of tyrosine kinase inhibitor (TKI) and the IC50 for c-Met, VEGFR2 and Axl are 6.7 nM, 1.9 nM and <1.0 nM respectively.",
    "Solubility": "DMSO: 16.67 mg/mL ",
    "MolFormula": "C31H29FN4O5",
    "MolWeight": "556.5842",
    "SMILES": "O=C(C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)NC3=CC=C(OC4=CC=NC5=CC(OCC(C)(O)C)=CC=C45)C(F)=C3",
    "Plate layout": "CSN-L1012-1-A2"
  },
  {
    "CASNum": "1628332-52-4",
    "CSN_Catalog_Num": "CSN23888",
    "Product_Name": "GSK467",
    "Synonyms": "/",
    "Target": "Histone Demethylase",
    "Pathway": "Epigenetics",
    "Brief": "GSK467 is a selective KDM5 inhibitor with Ki of 10 nM. It has no measurable inhibitory effects toward other JmJ family members.",
    "Solubility": "DMSO: 20.83 mg/mL ",
    "MolFormula": "C17H13N5O2",
    "MolWeight": "319.3174",
    "SMILES": "O=C1C2=C(C=NC=C2)N=C(OC3=CN(CC4=CC=CC=C4)N=C3)N1",
    "Plate layout": "CSN-L1012-1-A3"
  },
  {
    "CASNum": "18331-34-5",
    "CSN_Catalog_Num": "CSN23777",
    "Product_Name": "BTR-1",
    "Synonyms": "/",
    "Target": "Others-Others",
    "Pathway": "Others",
    "Brief": "BTR-1 is an active anti-cancer agent, causes S phase arrest, and affects DNA replication in leukemic cells. BTR-1 activates apoptosis and induces cell death[1].",
    "Solubility": "DMSO: 25 mg/mL ",
    "MolFormula": "C12H11NOS2",
    "MolWeight": "249.3518",
    "SMILES": "O=C1N(CC)C(S/C1=C\\C2=CC=CC=C2)=S",
    "Plate layout": "CSN-L1012-1-A4"
  },
  {
    "CASNum": "1534358-79-6",
    "CSN_Catalog_Num": "CSN23876",
    "Product_Name": "COH000",
    "Synonyms": "/",
    "Target": "Proteasome",
    "Pathway": "Protease|Ubiquitin",
    "Brief": "COH000 is an irreversible inhibitor of ubiquitin-like 1-activating enzyme (SUMO-activating enzyme) with IC50 of 0.2 μM for SUMOylation in vitro.",
    "Solubility": "DMSO: 35.71 mg/mL ",
    "MolFormula": "C25H25NO5",
    "MolWeight": "419.4700",
    "SMILES": "O=C(C1=C(C(OC)=O)[C@]2([H])C=C[C@@]1([C@H](NC3=CC=CC=C3)CC4=CC=C(C)C=C4)O2)OC",
    "Plate layout": "CSN-L1012-1-A5"
  },
  {
    "CASNum": "546-43-0",
    "CSN_Catalog_Num": "CSN16394",
    "Product_Name": "Alantolactone",
    "Synonyms": "Helenin; Helenine; Eupatal; (+)-Alantolactone",
    "Target": "Others-Others",
    "Pathway": "Others|Natural Product",
    "Brief": "Alantolactone is a sesquiterpene lactone with potential activity against triple-negative breast cancer MDA-MB-231 cells by suppressing the signal transducer and activator of transcription 3 (STAT3) signaling pathway.",
    "Solubility": "DMSO: 46 mg/mL ",
    "MolFormula": "C15H20O2",
    "MolWeight": "232.3200",
    "SMILES": "O=C(O[C@@]1([H])[C@]2([H])C=C3[C@@H](C)CCC[C@]3(C)C1)C2=C",
    "Plate layout": "CSN-L1012-1-A6"
  },
  {
    "CASNum": "2095704-43-9",
    "CSN_Catalog_Num": "CSN22507",
    "Product_Name": "SLV-2436",
    "Synonyms": "SEL201-88; SEL-201",
    "Target": "MNK",
    "Pathway": "MAPK/ERK Pathway",
    "Brief": "SLV-2436 is a highly potent and ATP-competitive inhibitor of MNK1 and MNK2 with IC50s of 10.8  nM and 5.4 nM, respectively.",
    "Solubility": "DMSO: ≥ 100 mg/mL",
    "MolFormula": "C19H15ClN4O",
    "MolWeight": "350.8000",
    "SMILES": "O=C1C=CC(C2=CC3=C(C=C2)C(N)=NN3)=CN1CC4=CC=CC(Cl)=C4",
    "Plate layout": "CSN-L1012-1-A7"
  },
  {
    "CASNum": "1801530-11-9",
    "CSN_Catalog_Num": "CSN24168",
    "Product_Name": "IKE",
    "Synonyms": "Imidazole ketone erastin",
    "Target": "Ferroptosis",
    "Pathway": "Metabolic Enzyme",
    "Brief": "IKE is a potent, metabolically stable inhibitor of system X<sub>c</sub><sup>-</sup> and inducer of ferroptosis potentially suitable for in vivo applications. ",
    "Solubility": "DMSO: ≥ 125 mg/mL",
    "MolFormula": "C35H35ClN6O5",
    "MolWeight": "655.1426",
    "SMILES": "O=C1N(C2=CC(C(CN3C=CN=C3)=O)=CC=C2OC(C)C)C(CN4CCN(C(COC5=CC=C(Cl)C=C5)=O)CC4)=NC6=C1C=CC=C6",
    "Plate layout": "CSN-L1012-1-A8"
  },
  {
    "CASNum": "1311423-89-8",
    "CSN_Catalog_Num": "CSN23787",
    "Product_Name": "YF-2",
    "Synonyms": "/",
    "Target": "Histone Acetyltransferase",
    "Pathway": "Epigenetics",
    "Brief": "YF-2 is a highly selective, blood-brain-barrier permeable histone acetyltransferase activator, acetylates H3 in the hippocampus, with EC50s of 2.75 μM, 29.04 μM and 49.31 μM for CBP, PCAF, and GCN5, respectively, shows no effect on HDAC. Anti-cancer and anti-Alzheimer's disease[1].",
    "Solubility": "DMSO: ≥ 125 mg/mL ",
    "MolFormula": "C20H22ClF3N2O3",
    "MolWeight": "430.8500",
    "SMILES": "O=C(NC1=CC=C(Cl)C(C(F)(F)F)=C1)C2=C(OCC)C=CC=C2OCCN(C)C",
    "Plate layout": "CSN-L1012-1-A9"
  }
]